With
Brian Dunphy,
Laurence Freedman
On Monday, the U.S. Court of Appeals for the Eleventh Circuit issued its long-awaited and closely watched decision in United States v. AseraCare Inc..
With
Laurence Freedman
Over the last two years, much of the healthcare world has been watching the government's prosecution of Insys Therapeutics for its sales and marketing practices related to its Subsys spray.
With
Brian Dunphy
As part of our ongoing discussion of the Polukoff False Claims Act (FCA) qui tam case (involving allegations that certain heart procedures performed by a cardiologist, and billed for by two hospital
As many of our readers know, we have been closely following the Polukoff False Claims Act (FCA) qui tam case in the Tenth Circuit for the lessons it might offer in defending FCA cases premised on
As many of our readers know, we have been closely following the Polukoff False Claims Act (FCA) qui tam case ...
Nearly one year ago, on January 25, 2018, the Department of Justice's (DOJ) Regulatory Reform Task Force issued a memorandum entitled
With
Laurence Freedman
In a three-sentence order issued on October 29th, the Tenth Circuit Court of Appeals declined to grant a Request for Rehearing in the closely watched Polukoff case.
Last week, Mintz's Health Care Enforcement Defense Group published a new Qui Tam Update, which analyzes 46 health care-related False Claims Act qui tam cases unsealed ...
With
Farrah Short,
Bruce Sokler
Last week, Bruce Sokler and Farrah Short from Mintz's Antitrust practice group published a detailed alert regarding the Third Circuit's reinstatement of an antitrust suit ...
With
Laurence Freedman
The all-too-common story of a healthcare company declaring bankruptcy in the face of aggressive Medicare recoupment actions before the company ...
Last week, the U.S. Attorney's Office for the District of Massachusetts announced that it had entered into an agreement with a Massachusetts-based medical device manufacturer...
As we predicted in our year-end post on civil and criminal enforcement trends, 2018 is already off to strong start in opioid-related enforcement against individual providers and associated practices.
Earlier this week, Mintz Levin's Health Care Enforcement Defense Group published its most recent Health Care Qui Tam Update.
With
Laurence Freedman,
Sarah Beth S. Kuyers
Earlier this week we released a Health Care Enforcement Advisory about a recent decision from the U.S. Court of Appeals for the Fifth Circuit that may have a significant impact ...
With
Laurence Freedman,
Sarah Beth S. Kuyers
The U.S. Court of Appeals for the Fifth Circuit recently decided a case that could have a substantial impact on False Claims Act ("FCA") jurisprudence with respect to the element of "materiality."
Based on Mondaq users readership, this author is ranked as Very Popular in United States for the topics, user groups and industry sectors listed below:
Topics
Financial RestructuringPosition
Consultant, Accountant in Accountancy Firm, Practicing AccountantIndustry
EducationHealthcare* Rankings are based on analysis of the last 12 months of Mondaq readership data across more than 25,000 contributing authors. To be ranked ‘Very Popular’ an author must be in the top 20% of results within the selected criteria.
